Oruka Therapeutics, Inc. · NASDAQ:ORKA
BlackRock, Inc. reported a 6.60% stake in Oruka Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Jan 21, 2026
BlackRock, Inc. reported a 6.60% stake in Oruka Therapeutics, Inc., 3,175,483 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G).
- Stake
- 6.60%
- Shares
- 3,175,483
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.60% | 3,175,483 |
Source
Related
- Oruka Therapeutics, Inc.
- BlackRock, Inc.
- Oruka Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Oct 17, 2025
- Schedule 13G · BlackRock, Inc. · Jul 17, 2025
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Goncalves Joana · Oct 15, 2026
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026